225 related articles for article (PubMed ID: 31819276)
1. CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing's sarcoma.
Ross NT; Lohmann F; Carbonneau S; Fazal A; Weihofen WA; Gleim S; Salcius M; Sigoillot F; Henault M; Carl SH; Rodríguez-Molina JB; Miller HR; Brittain SM; Murphy J; Zambrowski M; Boynton G; Wang Y; Chen A; Molind GJ; Wilbertz JH; Artus-Revel CG; Jia M; Akinjiyan FA; Turner J; Knehr J; Carbone W; Schuierer S; Reece-Hoyes JS; Xie K; Saran C; Williams ET; Roma G; Spencer M; Jenkins J; George EL; Thomas JR; Michaud G; Schirle M; Tallarico J; Passmore LA; Chao JA; Beckwith REJ
Nat Chem Biol; 2020 Jan; 16(1):50-59. PubMed ID: 31819276
[TBL] [Abstract][Full Text] [Related]
2. JTE-607, a multiple cytokine production inhibitor, targets CPSF3 and inhibits pre-mRNA processing.
Kakegawa J; Sakane N; Suzuki K; Yoshida T
Biochem Biophys Res Commun; 2019 Oct; 518(1):32-37. PubMed ID: 31399191
[TBL] [Abstract][Full Text] [Related]
3. CPSF3 inhibition blocks pancreatic cancer cell proliferation through disruption of core histone mRNA processing.
Alahmari AA; Chaubey AH; Jonnakuti VS; Tisdale AA; Schwarz CD; Cornwell AC; Maraszek KE; Paterson EJ; Kim M; Venkat S; Gomez EC; Wang J; Gurova KV; Yalamanchili HK; Feigin ME
RNA; 2024 Feb; 30(3):281-297. PubMed ID: 38191171
[TBL] [Abstract][Full Text] [Related]
4. Recent molecular insights into canonical pre-mRNA 3'-end processing.
Sun Y; Hamilton K; Tong L
Transcription; 2020 Apr; 11(2):83-96. PubMed ID: 32522085
[TBL] [Abstract][Full Text] [Related]
5. Potential use of imatinib in Ewing's Sarcoma: evidence for in vitro and in vivo activity.
Merchant MS; Woo CW; Mackall CL; Thiele CJ
J Natl Cancer Inst; 2002 Nov; 94(22):1673-9. PubMed ID: 12441322
[TBL] [Abstract][Full Text] [Related]
6. Anticancer benzoxaboroles block pre-mRNA processing by directly inhibiting CPSF3.
Tao Y; Budhipramono A; Huang J; Fang M; Xie S; Kim J; Khivansara V; Dominski Z; Tong L; De Brabander JK; Nijhawan D
Cell Chem Biol; 2024 Jan; 31(1):139-149.e14. PubMed ID: 37967558
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor.
Knowles HJ; Schaefer KL; Dirksen U; Athanasou NA
BMC Cancer; 2010 Jul; 10():372. PubMed ID: 20637078
[TBL] [Abstract][Full Text] [Related]
8. CSR1 induces cell death through inactivation of CPSF3.
Zhu ZH; Yu YP; Shi YK; Nelson JB; Luo JH
Oncogene; 2009 Jan; 28(1):41-51. PubMed ID: 18806823
[TBL] [Abstract][Full Text] [Related]
9. Small-molecule screen identifies modulators of EWS/FLI1 target gene expression and cell survival in Ewing's sarcoma.
Boro A; Prêtre K; Rechfeld F; Thalhammer V; Oesch S; Wachtel M; Schäfer BW; Niggli FK
Int J Cancer; 2012 Nov; 131(9):2153-64. PubMed ID: 22323082
[TBL] [Abstract][Full Text] [Related]
10. Clinical and veterinary trypanocidal benzoxaboroles target CPSF3.
Wall RJ; Rico E; Lukac I; Zuccotto F; Elg S; Gilbert IH; Freund Y; Alley MRK; Field MC; Wyllie S; Horn D
Proc Natl Acad Sci U S A; 2018 Sep; 115(38):9616-9621. PubMed ID: 30185555
[TBL] [Abstract][Full Text] [Related]
11. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
Nagano A; Ohno T; Shimizu K; Hara A; Yamamoto T; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Takei Y
Int J Cancer; 2010 Jun; 126(12):2790-8. PubMed ID: 19642105
[TBL] [Abstract][Full Text] [Related]
12. On the Cutting Edge: Regulation and Therapeutic Potential of the mRNA 3' End Nuclease.
Liu H; Moore CL
Trends Biochem Sci; 2021 Sep; 46(9):772-784. PubMed ID: 33941430
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
[TBL] [Abstract][Full Text] [Related]
14. High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition.
Awad O; Yustein JT; Shah P; Gul N; Katuri V; O'Neill A; Kong Y; Brown ML; Toretsky JA; Loeb DM
PLoS One; 2010 Nov; 5(11):e13943. PubMed ID: 21085683
[TBL] [Abstract][Full Text] [Related]
15. RNAi phenotype profiling of kinases identifies potential therapeutic targets in Ewing's sarcoma.
Arora S; Gonzales IM; Hagelstrom RT; Beaudry C; Choudhary A; Sima C; Tibes R; Mousses S; Azorsa DO
Mol Cancer; 2010 Aug; 9():218. PubMed ID: 20718987
[TBL] [Abstract][Full Text] [Related]
16. Overcoming cetuximab resistance in Ewing's sarcoma by inhibiting lactate dehydrogenase-A.
Fu J; Jiang H; Wu C; Jiang Y; Xiao L; Tian Y
Mol Med Rep; 2016 Jul; 14(1):995-1001. PubMed ID: 27222229
[TBL] [Abstract][Full Text] [Related]
17. R1507, an anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, and EWS/FLI-1 siRNA in Ewing's sarcoma: convergence at the IGF/IGFR/Akt axis.
Huang HJ; Angelo LS; Rodon J; Sun M; Kuenkele KP; Parsons HA; Trent JC; Kurzrock R
PLoS One; 2011; 6(10):e26060. PubMed ID: 22022506
[TBL] [Abstract][Full Text] [Related]
18. A real-time fluorescence assay for CPSF73, the nuclease for pre-mRNA 3'-end processing.
Gutierrez PA; Baughman K; Sun Y; Tong L
RNA; 2021 Oct; 27(10):1148-1154. PubMed ID: 34230059
[TBL] [Abstract][Full Text] [Related]
19. Preclinical studies of treosulfan demonstrate potent activity in Ewing's sarcoma.
Werner S; Mendoza A; Hilger RA; Erlacher M; Reichardt W; Lissat A; Konanz C; Uhl M; Niemeyer CM; Khanna C; Kontny U
Cancer Chemother Pharmacol; 2008 Jun; 62(1):19-31. PubMed ID: 17823799
[TBL] [Abstract][Full Text] [Related]
20. Author Correction: CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing's sarcoma.
Ross NT; Lohmann F; Carbonneau S; Fazal A; Weihofen WA; Gleim S; Salcius M; Sigoillot F; Henault M; Carl SH; Rodríguez-Molina JB; Miller HR; Brittain SM; Murphy J; Zambrowski M; Boynton G; Wang Y; Chen A; Molind GJ; Wilbertz JH; Artus-Revel CG; Jia M; Akinjiyan FA; Turner J; Knehr J; Carbone W; Schuierer S; Reece-Hoyes JS; Xie K; Saran C; Williams ET; Roma G; Spencer M; Jenkins J; George EL; Thomas JR; Michaud G; Schirle M; Tallarico J; Passmore LA; Chao JA; Beckwith REJ
Nat Chem Biol; 2020 Apr; 16(4):479. PubMed ID: 32139909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
